INDUSTRY SYMPOSIUM // ALEXION - Legacy and Innovation: The Potential of Complement in Myasthenia Gravis

17:30 • SYMP6L1 • Welcome and Introductions 17:35 • SYMP6L2 • Burden of Disease and Role of Complement in MG > A. Anthony BÉHIN (Paris, France) 17:43 • SYMP6L3 • Complement inhibition as a target for MG treatment > D. Djillali ANNANE (Paris, France) 18:03 • SYMP6L4 • MG Treatment guidelines in the context of Clinical Practice in France > A. Anthony BÉHIN (Paris, France) 18:13 • SYMP6L5 • Summary and close 18:28 • SYMP6L6 • Discussion and Q&A